Report states India`s USD1 pill could be main reason to healing cancer menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
The Tata Institute in Mumbai has developed a tablet that could prevent cancer from recurring and reduce side effects of treatment by 50%. The tablet, which will cost just ₹100, is awaiting approval from the Food Safety and Standards Authority of India (FSSAI) and could be available in the market by June-July.
After a decade of work, a team of researchers and doctors at the Tata Institute in Mumbai have developed a novel drug that aims to prevent cancer recurrence in patients. Cancer Tablet in Rs 100: Tata Institute Claims New Breakthrough in Cancer Prevention.
In a major medical breakthrough, a study conducted by the Tata Memorial Institute in Mumbai has resulted in the development of a Rs 100 tablet, which the researchers claim will prevent the relapse of cancer
Tata Institute doctors claim new drug prevents cancer recurrence indiatoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatoday.in Daily Mail and Mail on Sunday newspapers.